nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—peripheral nervous system neoplasm—head and neck cancer	0.454	1	CtDrD
Alitretinoin—RARB—head and neck cancer	0.397	1	CbGaD
Alitretinoin—RARG—tongue—head and neck cancer	0.00138	0.0777	CbGeAlD
Alitretinoin—Isotretinoin—RARB—head and neck cancer	0.00138	0.363	CrCbGaD
Alitretinoin—CRABP2—mouth—head and neck cancer	0.00128	0.0716	CbGeAlD
Alitretinoin—CRABP1—neck—head and neck cancer	0.00121	0.0677	CbGeAlD
Alitretinoin—Acitretin—RARB—head and neck cancer	0.00118	0.309	CrCbGaD
Alitretinoin—RXRG—neck—head and neck cancer	0.000954	0.0535	CbGeAlD
Alitretinoin—RARG—mouth—head and neck cancer	0.000931	0.0523	CbGeAlD
Alitretinoin—CRABP2—parotid gland—head and neck cancer	0.000889	0.0499	CbGeAlD
Alitretinoin—CRABP1—connective tissue—head and neck cancer	0.000865	0.0485	CbGeAlD
Alitretinoin—Tretinoin—RARB—head and neck cancer	0.000794	0.209	CrCbGaD
Alitretinoin—CRABP2—connective tissue—head and neck cancer	0.000782	0.0439	CbGeAlD
Alitretinoin—CRABP1—trachea—head and neck cancer	0.000726	0.0407	CbGeAlD
Alitretinoin—CRABP2—trachea—head and neck cancer	0.000657	0.0369	CbGeAlD
Alitretinoin—CRABP1—thyroid gland—head and neck cancer	0.000574	0.0322	CbGeAlD
Alitretinoin—CRABP2—thyroid gland—head and neck cancer	0.000519	0.0292	CbGeAlD
Alitretinoin—CRABP1—head—head and neck cancer	0.00051	0.0286	CbGeAlD
Alitretinoin—RARB—thyroid gland—head and neck cancer	0.000465	0.0261	CbGeAlD
Alitretinoin—CRABP2—head—head and neck cancer	0.000461	0.0259	CbGeAlD
Alitretinoin—RXRA—head—head and neck cancer	0.000459	0.0257	CbGeAlD
Alitretinoin—RXRG—thyroid gland—head and neck cancer	0.000454	0.0255	CbGeAlD
Alitretinoin—RXRB—thyroid gland—head and neck cancer	0.000427	0.024	CbGeAlD
Alitretinoin—RARB—head—head and neck cancer	0.000412	0.0231	CbGeAlD
Alitretinoin—RXRG—head—head and neck cancer	0.000403	0.0226	CbGeAlD
Alitretinoin—RARA—lymphoid tissue—head and neck cancer	0.000392	0.022	CbGeAlD
Alitretinoin—RARG—thyroid gland—head and neck cancer	0.000379	0.0213	CbGeAlD
Alitretinoin—RXRB—head—head and neck cancer	0.000379	0.0213	CbGeAlD
Alitretinoin—RARA—thyroid gland—head and neck cancer	0.000356	0.02	CbGeAlD
Alitretinoin—RARG—head—head and neck cancer	0.000336	0.0189	CbGeAlD
Alitretinoin—RARA—head—head and neck cancer	0.000316	0.0177	CbGeAlD
Alitretinoin—RARB—lymph node—head and neck cancer	0.000289	0.0162	CbGeAlD
Alitretinoin—RARG—lymph node—head and neck cancer	0.000235	0.0132	CbGeAlD
Alitretinoin—Vitamin A—CYP1A1—head and neck cancer	0.000231	0.0606	CrCbGaD
Alitretinoin—Tretinoin—CYP1A1—head and neck cancer	0.000223	0.0585	CrCbGaD
Alitretinoin—RARA—lymph node—head and neck cancer	0.000221	0.0124	CbGeAlD
Alitretinoin—Haemoglobin—Vinblastine—head and neck cancer	0.000175	0.00247	CcSEcCtD
Alitretinoin—Haemorrhage—Vinblastine—head and neck cancer	0.000174	0.00246	CcSEcCtD
Alitretinoin—Blood bilirubin increased—Docetaxel—head and neck cancer	0.000173	0.00245	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000173	0.00245	CcSEcCtD
Alitretinoin—Hypoaesthesia—Vinblastine—head and neck cancer	0.000173	0.00245	CcSEcCtD
Alitretinoin—Dermatitis bullous—Fluorouracil—head and neck cancer	0.000173	0.00244	CcSEcCtD
Alitretinoin—Pharyngitis—Vinblastine—head and neck cancer	0.000172	0.00244	CcSEcCtD
Alitretinoin—Hearing impaired—Docetaxel—head and neck cancer	0.000172	0.00244	CcSEcCtD
Alitretinoin—Stomatitis—Hydroxyurea—head and neck cancer	0.000172	0.00244	CcSEcCtD
Alitretinoin—Bone pain—Docetaxel—head and neck cancer	0.000171	0.00242	CcSEcCtD
Alitretinoin—Inflammation—Docetaxel—head and neck cancer	0.000169	0.00239	CcSEcCtD
Alitretinoin—Cardiac failure—Fluorouracil—head and neck cancer	0.000169	0.00239	CcSEcCtD
Alitretinoin—Lethargy—Fluorouracil—head and neck cancer	0.000168	0.00238	CcSEcCtD
Alitretinoin—Respiratory failure—Docetaxel—head and neck cancer	0.000167	0.00236	CcSEcCtD
Alitretinoin—Osteoarthritis—Fluorouracil—head and neck cancer	0.000165	0.00233	CcSEcCtD
Alitretinoin—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000165	0.00233	CcSEcCtD
Alitretinoin—Hepatocellular injury—Docetaxel—head and neck cancer	0.000164	0.00232	CcSEcCtD
Alitretinoin—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.000164	0.00232	CcSEcCtD
Alitretinoin—Injection site reaction—Docetaxel—head and neck cancer	0.000163	0.00231	CcSEcCtD
Alitretinoin—Haemoglobin—Hydroxyurea—head and neck cancer	0.000159	0.00225	CcSEcCtD
Alitretinoin—Haemorrhage—Hydroxyurea—head and neck cancer	0.000158	0.00224	CcSEcCtD
Alitretinoin—Hallucination—Hydroxyurea—head and neck cancer	0.000158	0.00223	CcSEcCtD
Alitretinoin—Colitis—Docetaxel—head and neck cancer	0.000157	0.00223	CcSEcCtD
Alitretinoin—Irritability—Fluorouracil—head and neck cancer	0.000157	0.00223	CcSEcCtD
Alitretinoin—Cardiac arrest—Fluorouracil—head and neck cancer	0.000157	0.00222	CcSEcCtD
Alitretinoin—Skin exfoliation—Docetaxel—head and neck cancer	0.000157	0.00222	CcSEcCtD
Alitretinoin—Candida infection—Docetaxel—head and neck cancer	0.000157	0.00222	CcSEcCtD
Alitretinoin—Alopecia—Vinblastine—head and neck cancer	0.000154	0.00217	CcSEcCtD
Alitretinoin—Dry skin—Fluorouracil—head and neck cancer	0.000151	0.00214	CcSEcCtD
Alitretinoin—Oesophagitis—Docetaxel—head and neck cancer	0.00015	0.00212	CcSEcCtD
Alitretinoin—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000147	0.00209	CcSEcCtD
Alitretinoin—Lightheadedness—Docetaxel—head and neck cancer	0.000147	0.00208	CcSEcCtD
Alitretinoin—Pulmonary oedema—Docetaxel—head and neck cancer	0.000146	0.00207	CcSEcCtD
Alitretinoin—Angiopathy—Hydroxyurea—head and neck cancer	0.000144	0.00204	CcSEcCtD
Alitretinoin—Dysphagia—Fluorouracil—head and neck cancer	0.000143	0.00202	CcSEcCtD
Alitretinoin—Sepsis—Docetaxel—head and neck cancer	0.000142	0.00201	CcSEcCtD
Alitretinoin—Chills—Hydroxyurea—head and neck cancer	0.000142	0.00201	CcSEcCtD
Alitretinoin—Ill-defined disorder—Vinblastine—head and neck cancer	0.00014	0.00199	CcSEcCtD
Alitretinoin—Alopecia—Hydroxyurea—head and neck cancer	0.00014	0.00198	CcSEcCtD
Alitretinoin—Anaemia—Vinblastine—head and neck cancer	0.00014	0.00198	CcSEcCtD
Alitretinoin—Phlebitis—Docetaxel—head and neck cancer	0.000138	0.00196	CcSEcCtD
Alitretinoin—Erythema—Hydroxyurea—head and neck cancer	0.000138	0.00195	CcSEcCtD
Alitretinoin—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000137	0.00194	CcSEcCtD
Alitretinoin—Malaise—Vinblastine—head and neck cancer	0.000136	0.00193	CcSEcCtD
Alitretinoin—RXRG—a6b1 and a6b4 Integrin signaling—HRAS—head and neck cancer	0.000136	0.00242	CbGpPWpGaD
Alitretinoin—Swelling—Docetaxel—head and neck cancer	0.000135	0.00191	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—RARB—head and neck cancer	0.000134	0.00239	CbGpPWpGaD
Alitretinoin—Deafness—Docetaxel—head and neck cancer	0.000133	0.00188	CcSEcCtD
Alitretinoin—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000132	0.00187	CcSEcCtD
Alitretinoin—CYP1A2—thyroid gland—head and neck cancer	0.000132	0.00741	CbGeAlD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000132	0.00236	CbGpPWpGaD
Alitretinoin—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000131	0.00186	CcSEcCtD
Alitretinoin—Convulsion—Vinblastine—head and neck cancer	0.000131	0.00186	CcSEcCtD
Alitretinoin—Hypertension—Vinblastine—head and neck cancer	0.000131	0.00185	CcSEcCtD
Alitretinoin—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.00013	0.00233	CbGpPWpGaD
Alitretinoin—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00013	0.00184	CcSEcCtD
Alitretinoin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000128	0.00181	CcSEcCtD
Alitretinoin—Pneumonia—Fluorouracil—head and neck cancer	0.000128	0.00181	CcSEcCtD
Alitretinoin—Anaemia—Hydroxyurea—head and neck cancer	0.000128	0.0018	CcSEcCtD
Alitretinoin—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—head and neck cancer	0.000127	0.00228	CbGpPWpGaD
Alitretinoin—Discomfort—Vinblastine—head and neck cancer	0.000127	0.0018	CcSEcCtD
Alitretinoin—Infestation NOS—Fluorouracil—head and neck cancer	0.000127	0.0018	CcSEcCtD
Alitretinoin—Infestation—Fluorouracil—head and neck cancer	0.000127	0.0018	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000126	0.00226	CbGpPWpGaD
Alitretinoin—RXRA—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000126	0.00226	CbGpPWpGaD
Alitretinoin—Visual disturbance—Docetaxel—head and neck cancer	0.000126	0.00178	CcSEcCtD
Alitretinoin—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000125	0.00177	CcSEcCtD
Alitretinoin—Renal impairment—Docetaxel—head and neck cancer	0.000125	0.00177	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000125	0.00176	CcSEcCtD
Alitretinoin—Myocardial infarction—Fluorouracil—head and neck cancer	0.000125	0.00176	CcSEcCtD
Alitretinoin—Dermatitis bullous—Docetaxel—head and neck cancer	0.000125	0.00176	CcSEcCtD
Alitretinoin—Malaise—Hydroxyurea—head and neck cancer	0.000124	0.00176	CcSEcCtD
Alitretinoin—Stomatitis—Fluorouracil—head and neck cancer	0.000124	0.00175	CcSEcCtD
Alitretinoin—Conjunctivitis—Fluorouracil—head and neck cancer	0.000124	0.00175	CcSEcCtD
Alitretinoin—Urinary tract infection—Fluorouracil—head and neck cancer	0.000124	0.00175	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—RARB—head and neck cancer	0.000122	0.00219	CbGpPWpGaD
Alitretinoin—Cardiac failure—Docetaxel—head and neck cancer	0.000122	0.00173	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—YAP1—head and neck cancer	0.000122	0.00217	CbGpPWpGaD
Alitretinoin—Lethargy—Docetaxel—head and neck cancer	0.000121	0.00172	CcSEcCtD
Alitretinoin—Thrombocytopenia—Vinblastine—head and neck cancer	0.000121	0.00171	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000121	0.00216	CbGpPWpGaD
Alitretinoin—RXRA—Retinoic acid receptors-mediated signaling—MAPK3—head and neck cancer	0.00012	0.00215	CbGpPWpGaD
Alitretinoin—Epistaxis—Fluorouracil—head and neck cancer	0.00012	0.0017	CcSEcCtD
Alitretinoin—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.00012	0.00214	CbGpPWpGaD
Alitretinoin—RXRG—a6b1 and a6b4 Integrin signaling—AKT1—head and neck cancer	0.00012	0.00214	CbGpPWpGaD
Alitretinoin—Convulsion—Hydroxyurea—head and neck cancer	0.00012	0.00169	CcSEcCtD
Alitretinoin—Sinusitis—Fluorouracil—head and neck cancer	0.000119	0.00169	CcSEcCtD
Alitretinoin—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000119	0.00168	CcSEcCtD
Alitretinoin—Pain in extremity—Docetaxel—head and neck cancer	0.000119	0.00168	CcSEcCtD
Alitretinoin—Agranulocytosis—Fluorouracil—head and neck cancer	0.000119	0.00168	CcSEcCtD
Alitretinoin—Anorexia—Vinblastine—head and neck cancer	0.000118	0.00167	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000117	0.00165	CcSEcCtD
Alitretinoin—Discomfort—Hydroxyurea—head and neck cancer	0.000116	0.00164	CcSEcCtD
Alitretinoin—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000115	0.00206	CbGpPWpGaD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—head and neck cancer	0.000115	0.00206	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—RARB—head and neck cancer	0.000115	0.00206	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—RARB—head and neck cancer	0.000115	0.00206	CbGpPWpGaD
Alitretinoin—Haemoglobin—Fluorouracil—head and neck cancer	0.000115	0.00162	CcSEcCtD
Alitretinoin—RXRA—Retinoic acid receptors-mediated signaling—MAPK1—head and neck cancer	0.000114	0.00205	CbGpPWpGaD
Alitretinoin—Haemorrhage—Fluorouracil—head and neck cancer	0.000114	0.00161	CcSEcCtD
Alitretinoin—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000113	0.00161	CcSEcCtD
Alitretinoin—Pharyngitis—Fluorouracil—head and neck cancer	0.000113	0.0016	CcSEcCtD
Alitretinoin—Oedema—Hydroxyurea—head and neck cancer	0.000113	0.00159	CcSEcCtD
Alitretinoin—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—head and neck cancer	0.000112	0.00201	CbGpPWpGaD
Alitretinoin—Infection—Hydroxyurea—head and neck cancer	0.000112	0.00158	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—YAP1—head and neck cancer	0.000111	0.00199	CbGpPWpGaD
Alitretinoin—Paraesthesia—Vinblastine—head and neck cancer	0.000111	0.00157	CcSEcCtD
Alitretinoin—Dehydration—Docetaxel—head and neck cancer	0.000111	0.00157	CcSEcCtD
Alitretinoin—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00011	0.00156	CcSEcCtD
Alitretinoin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00011	0.00156	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.00011	0.00196	CbGpPWpGaD
Alitretinoin—Skin disorder—Hydroxyurea—head and neck cancer	0.000109	0.00155	CcSEcCtD
Alitretinoin—Dry skin—Docetaxel—head and neck cancer	0.000109	0.00154	CcSEcCtD
Alitretinoin—RARB—Generic Transcription Pathway—YAP1—head and neck cancer	0.000109	0.00195	CbGpPWpGaD
Alitretinoin—Anorexia—Hydroxyurea—head and neck cancer	0.000107	0.00152	CcSEcCtD
Alitretinoin—Decreased appetite—Vinblastine—head and neck cancer	0.000107	0.00152	CcSEcCtD
Alitretinoin—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000107	0.00152	CcSEcCtD
Alitretinoin—Nasopharyngitis—Docetaxel—head and neck cancer	0.000106	0.00151	CcSEcCtD
Alitretinoin—Pain—Vinblastine—head and neck cancer	0.000106	0.00149	CcSEcCtD
Alitretinoin—Constipation—Vinblastine—head and neck cancer	0.000106	0.00149	CcSEcCtD
Alitretinoin—RXRB—Generic Transcription Pathway—YAP1—head and neck cancer	0.000105	0.00187	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—YAP1—head and neck cancer	0.000105	0.00187	CbGpPWpGaD
Alitretinoin—Dysphagia—Docetaxel—head and neck cancer	0.000103	0.00146	CcSEcCtD
Alitretinoin—Arrhythmia—Fluorouracil—head and neck cancer	0.000102	0.00144	CcSEcCtD
Alitretinoin—Feeling abnormal—Vinblastine—head and neck cancer	0.000102	0.00144	CcSEcCtD
Alitretinoin—Bronchospasm—Docetaxel—head and neck cancer	0.000101	0.00143	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000101	0.00143	CcSEcCtD
Alitretinoin—Alopecia—Fluorouracil—head and neck cancer	0.000101	0.00143	CcSEcCtD
Alitretinoin—Dyspnoea—Hydroxyurea—head and neck cancer	0.0001	0.00142	CcSEcCtD
Alitretinoin—Somnolence—Hydroxyurea—head and neck cancer	0.0001	0.00142	CcSEcCtD
Alitretinoin—Erythema—Fluorouracil—head and neck cancer	9.93e-05	0.00141	CcSEcCtD
Alitretinoin—Dyspepsia—Hydroxyurea—head and neck cancer	9.91e-05	0.0014	CcSEcCtD
Alitretinoin—Decreased appetite—Hydroxyurea—head and neck cancer	9.79e-05	0.00139	CcSEcCtD
Alitretinoin—Abdominal pain—Vinblastine—head and neck cancer	9.76e-05	0.00138	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	9.72e-05	0.00138	CcSEcCtD
Alitretinoin—Fatigue—Hydroxyurea—head and neck cancer	9.71e-05	0.00137	CcSEcCtD
Alitretinoin—ABCB1—epithelium—head and neck cancer	9.68e-05	0.00543	CbGeAlD
Alitretinoin—Pain—Hydroxyurea—head and neck cancer	9.63e-05	0.00136	CcSEcCtD
Alitretinoin—Constipation—Hydroxyurea—head and neck cancer	9.63e-05	0.00136	CcSEcCtD
Alitretinoin—Neutropenia—Docetaxel—head and neck cancer	9.62e-05	0.00136	CcSEcCtD
Alitretinoin—RXRA—PPARA activates gene expression—CYP1A1—head and neck cancer	9.6e-05	0.00172	CbGpPWpGaD
Alitretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—head and neck cancer	9.39e-05	0.00168	CbGpPWpGaD
Alitretinoin—Weight increased—Docetaxel—head and neck cancer	9.36e-05	0.00132	CcSEcCtD
Alitretinoin—Vision blurred—Fluorouracil—head and neck cancer	9.36e-05	0.00132	CcSEcCtD
Alitretinoin—Weight decreased—Docetaxel—head and neck cancer	9.31e-05	0.00132	CcSEcCtD
Alitretinoin—Feeling abnormal—Hydroxyurea—head and neck cancer	9.28e-05	0.00131	CcSEcCtD
Alitretinoin—Pneumonia—Docetaxel—head and neck cancer	9.22e-05	0.00131	CcSEcCtD
Alitretinoin—Anaemia—Fluorouracil—head and neck cancer	9.18e-05	0.0013	CcSEcCtD
Alitretinoin—Infestation—Docetaxel—head and neck cancer	9.17e-05	0.0013	CcSEcCtD
Alitretinoin—Infestation NOS—Docetaxel—head and neck cancer	9.17e-05	0.0013	CcSEcCtD
Alitretinoin—Hypersensitivity—Vinblastine—head and neck cancer	9.1e-05	0.00129	CcSEcCtD
Alitretinoin—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	9.09e-05	0.00129	CcSEcCtD
Alitretinoin—Acute coronary syndrome—Docetaxel—head and neck cancer	9.04e-05	0.00128	CcSEcCtD
Alitretinoin—Renal failure—Docetaxel—head and neck cancer	9.02e-05	0.00128	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	9.01e-05	0.00161	CbGpPWpGaD
Alitretinoin—Neuropathy peripheral—Docetaxel—head and neck cancer	8.99e-05	0.00127	CcSEcCtD
Alitretinoin—Myocardial infarction—Docetaxel—head and neck cancer	8.99e-05	0.00127	CcSEcCtD
Alitretinoin—Stomatitis—Docetaxel—head and neck cancer	8.94e-05	0.00127	CcSEcCtD
Alitretinoin—Conjunctivitis—Docetaxel—head and neck cancer	8.91e-05	0.00126	CcSEcCtD
Alitretinoin—Body temperature increased—Hydroxyurea—head and neck cancer	8.9e-05	0.00126	CcSEcCtD
Alitretinoin—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	8.89e-05	0.00159	CbGpPWpGaD
Alitretinoin—Asthenia—Vinblastine—head and neck cancer	8.86e-05	0.00125	CcSEcCtD
Alitretinoin—Epistaxis—Docetaxel—head and neck cancer	8.65e-05	0.00122	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	8.64e-05	0.00155	CbGpPWpGaD
Alitretinoin—Convulsion—Fluorouracil—head and neck cancer	8.6e-05	0.00122	CcSEcCtD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.6e-05	0.00154	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.6e-05	0.00154	CbGpPWpGaD
Alitretinoin—RXRA—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	8.58e-05	0.00153	CbGpPWpGaD
Alitretinoin—Agranulocytosis—Docetaxel—head and neck cancer	8.56e-05	0.00121	CcSEcCtD
Alitretinoin—ABCB1—trachea—head and neck cancer	8.56e-05	0.0048	CbGeAlD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.51e-05	0.00152	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.51e-05	0.00152	CbGpPWpGaD
Alitretinoin—Chest pain—Fluorouracil—head and neck cancer	8.45e-05	0.0012	CcSEcCtD
Alitretinoin—Myalgia—Fluorouracil—head and neck cancer	8.45e-05	0.0012	CcSEcCtD
Alitretinoin—Diarrhoea—Vinblastine—head and neck cancer	8.45e-05	0.0012	CcSEcCtD
Alitretinoin—Discomfort—Fluorouracil—head and neck cancer	8.35e-05	0.00118	CcSEcCtD
Alitretinoin—Hypersensitivity—Hydroxyurea—head and neck cancer	8.3e-05	0.00117	CcSEcCtD
Alitretinoin—Haemoglobin—Docetaxel—head and neck cancer	8.27e-05	0.00117	CcSEcCtD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—head and neck cancer	8.27e-05	0.00148	CbGpPWpGaD
Alitretinoin—Haemorrhage—Docetaxel—head and neck cancer	8.23e-05	0.00117	CcSEcCtD
Alitretinoin—Hepatitis—Docetaxel—head and neck cancer	8.23e-05	0.00117	CcSEcCtD
Alitretinoin—Hypoaesthesia—Docetaxel—head and neck cancer	8.19e-05	0.00116	CcSEcCtD
Alitretinoin—Confusional state—Fluorouracil—head and neck cancer	8.17e-05	0.00116	CcSEcCtD
Alitretinoin—Pharyngitis—Docetaxel—head and neck cancer	8.17e-05	0.00116	CcSEcCtD
Alitretinoin—Dizziness—Vinblastine—head and neck cancer	8.16e-05	0.00116	CcSEcCtD
Alitretinoin—Urinary tract disorder—Docetaxel—head and neck cancer	8.13e-05	0.00115	CcSEcCtD
Alitretinoin—Oedema peripheral—Docetaxel—head and neck cancer	8.11e-05	0.00115	CcSEcCtD
Alitretinoin—RXRA—Retinoic acid receptors-mediated signaling—AKT1—head and neck cancer	8.11e-05	0.00145	CbGpPWpGaD
Alitretinoin—Oedema—Fluorouracil—head and neck cancer	8.1e-05	0.00115	CcSEcCtD
Alitretinoin—Anaphylactic shock—Fluorouracil—head and neck cancer	8.1e-05	0.00115	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—NAT2—head and neck cancer	8.1e-05	0.00145	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—NAT2—head and neck cancer	8.1e-05	0.00145	CbGpPWpGaD
Alitretinoin—Asthenia—Hydroxyurea—head and neck cancer	8.08e-05	0.00114	CcSEcCtD
Alitretinoin—Urethral disorder—Docetaxel—head and neck cancer	8.07e-05	0.00114	CcSEcCtD
Alitretinoin—RXRA—NRF2 pathway—GSTM1—head and neck cancer	8.07e-05	0.00144	CbGpPWpGaD
Alitretinoin—Infection—Fluorouracil—head and neck cancer	8.05e-05	0.00114	CcSEcCtD
Alitretinoin—Nervous system disorder—Fluorouracil—head and neck cancer	7.95e-05	0.00112	CcSEcCtD
Alitretinoin—RXRG—Adipogenesis—STAT3—head and neck cancer	7.95e-05	0.00142	CbGpPWpGaD
Alitretinoin—Thrombocytopenia—Fluorouracil—head and neck cancer	7.93e-05	0.00112	CcSEcCtD
Alitretinoin—Visual impairment—Docetaxel—head and neck cancer	7.93e-05	0.00112	CcSEcCtD
Alitretinoin—Tachycardia—Fluorouracil—head and neck cancer	7.91e-05	0.00112	CcSEcCtD
Alitretinoin—Vomiting—Vinblastine—head and neck cancer	7.85e-05	0.00111	CcSEcCtD
Alitretinoin—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	7.84e-05	0.0014	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	7.82e-05	0.0014	CbGpPWpGaD
Alitretinoin—Erythema multiforme—Docetaxel—head and neck cancer	7.78e-05	0.0011	CcSEcCtD
Alitretinoin—Headache—Vinblastine—head and neck cancer	7.73e-05	0.00109	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	7.73e-05	0.00138	CbGpPWpGaD
Alitretinoin—Anorexia—Fluorouracil—head and neck cancer	7.72e-05	0.00109	CcSEcCtD
Alitretinoin—Diarrhoea—Hydroxyurea—head and neck cancer	7.7e-05	0.00109	CcSEcCtD
Alitretinoin—Eye disorder—Docetaxel—head and neck cancer	7.69e-05	0.00109	CcSEcCtD
Alitretinoin—Flushing—Docetaxel—head and neck cancer	7.64e-05	0.00108	CcSEcCtD
Alitretinoin—Hypotension—Fluorouracil—head and neck cancer	7.57e-05	0.00107	CcSEcCtD
Alitretinoin—RARA—Adipogenesis—STAT3—head and neck cancer	7.47e-05	0.00134	CbGpPWpGaD
Alitretinoin—Angiopathy—Docetaxel—head and neck cancer	7.47e-05	0.00106	CcSEcCtD
Alitretinoin—ABCB1—lymphoid tissue—head and neck cancer	7.45e-05	0.00418	CbGeAlD
Alitretinoin—Dizziness—Hydroxyurea—head and neck cancer	7.45e-05	0.00105	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	7.41e-05	0.00133	CbGpPWpGaD
Alitretinoin—Chills—Docetaxel—head and neck cancer	7.39e-05	0.00105	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	7.38e-05	0.00105	CcSEcCtD
Alitretinoin—Arrhythmia—Docetaxel—head and neck cancer	7.35e-05	0.00104	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	7.34e-05	0.00131	CbGpPWpGaD
Alitretinoin—Nausea—Vinblastine—head and neck cancer	7.33e-05	0.00104	CcSEcCtD
Alitretinoin—Insomnia—Fluorouracil—head and neck cancer	7.33e-05	0.00104	CcSEcCtD
Alitretinoin—Paraesthesia—Fluorouracil—head and neck cancer	7.28e-05	0.00103	CcSEcCtD
Alitretinoin—Alopecia—Docetaxel—head and neck cancer	7.28e-05	0.00103	CcSEcCtD
Alitretinoin—RXRA—Developmental Biology—CEBPA—head and neck cancer	7.25e-05	0.0013	CbGpPWpGaD
Alitretinoin—Dyspnoea—Fluorouracil—head and neck cancer	7.23e-05	0.00102	CcSEcCtD
Alitretinoin—Mental disorder—Docetaxel—head and neck cancer	7.21e-05	0.00102	CcSEcCtD
Alitretinoin—Somnolence—Fluorouracil—head and neck cancer	7.2e-05	0.00102	CcSEcCtD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—PIK3CA—head and neck cancer	7.18e-05	0.00128	CbGpPWpGaD
Alitretinoin—Malnutrition—Docetaxel—head and neck cancer	7.17e-05	0.00101	CcSEcCtD
Alitretinoin—Erythema—Docetaxel—head and neck cancer	7.17e-05	0.00101	CcSEcCtD
Alitretinoin—Vomiting—Hydroxyurea—head and neck cancer	7.16e-05	0.00101	CcSEcCtD
Alitretinoin—Dyspepsia—Fluorouracil—head and neck cancer	7.13e-05	0.00101	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—DPYD—head and neck cancer	7.1e-05	0.00127	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—DPYD—head and neck cancer	7.1e-05	0.00127	CbGpPWpGaD
Alitretinoin—Rash—Hydroxyurea—head and neck cancer	7.1e-05	0.001	CcSEcCtD
Alitretinoin—Dermatitis—Hydroxyurea—head and neck cancer	7.09e-05	0.001	CcSEcCtD
Alitretinoin—RXRA—Biological oxidations—GSTM1—head and neck cancer	7.08e-05	0.00127	CbGpPWpGaD
Alitretinoin—Headache—Hydroxyurea—head and neck cancer	7.05e-05	0.000998	CcSEcCtD
Alitretinoin—Decreased appetite—Fluorouracil—head and neck cancer	7.04e-05	0.000997	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	7.04e-05	0.00126	CbGpPWpGaD
Alitretinoin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	7e-05	0.00099	CcSEcCtD
Alitretinoin—Back pain—Docetaxel—head and neck cancer	6.93e-05	0.000981	CcSEcCtD
Alitretinoin—Pain—Fluorouracil—head and neck cancer	6.93e-05	0.000981	CcSEcCtD
Alitretinoin—ABCB1—thyroid gland—head and neck cancer	6.77e-05	0.0038	CbGeAlD
Alitretinoin—CRABP2—Metabolism—YAP1—head and neck cancer	6.74e-05	0.00121	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—YAP1—head and neck cancer	6.74e-05	0.00121	CbGpPWpGaD
Alitretinoin—RXRA—Biological oxidations—CYP1A1—head and neck cancer	6.71e-05	0.0012	CbGpPWpGaD
Alitretinoin—Nausea—Hydroxyurea—head and neck cancer	6.69e-05	0.000947	CcSEcCtD
Alitretinoin—Feeling abnormal—Fluorouracil—head and neck cancer	6.68e-05	0.000945	CcSEcCtD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—head and neck cancer	6.64e-05	0.00119	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	6.64e-05	0.00119	CbGpPWpGaD
Alitretinoin—Anaemia—Docetaxel—head and neck cancer	6.62e-05	0.000938	CcSEcCtD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ATP7B—head and neck cancer	6.62e-05	0.00118	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	6.59e-05	0.00118	CbGpPWpGaD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—head and neck cancer	6.47e-05	0.00116	CbGpPWpGaD
Alitretinoin—Urticaria—Fluorouracil—head and neck cancer	6.44e-05	0.000911	CcSEcCtD
Alitretinoin—RARG—Gene Expression—RARB—head and neck cancer	6.43e-05	0.00115	CbGpPWpGaD
Alitretinoin—Syncope—Docetaxel—head and neck cancer	6.43e-05	0.00091	CcSEcCtD
Alitretinoin—Body temperature increased—Fluorouracil—head and neck cancer	6.41e-05	0.000907	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	6.41e-05	0.00115	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	6.36e-05	0.00114	CbGpPWpGaD
Alitretinoin—Palpitations—Docetaxel—head and neck cancer	6.33e-05	0.000896	CcSEcCtD
Alitretinoin—Loss of consciousness—Docetaxel—head and neck cancer	6.3e-05	0.000892	CcSEcCtD
Alitretinoin—Cough—Docetaxel—head and neck cancer	6.25e-05	0.000885	CcSEcCtD
Alitretinoin—Convulsion—Docetaxel—head and neck cancer	6.21e-05	0.000879	CcSEcCtD
Alitretinoin—Hypertension—Docetaxel—head and neck cancer	6.19e-05	0.000876	CcSEcCtD
Alitretinoin—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	6.15e-05	0.0011	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	6.15e-05	0.0011	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	6.15e-05	0.0011	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	6.14e-05	0.0011	CbGpPWpGaD
Alitretinoin—Chest pain—Docetaxel—head and neck cancer	6.1e-05	0.000864	CcSEcCtD
Alitretinoin—Myalgia—Docetaxel—head and neck cancer	6.1e-05	0.000864	CcSEcCtD
Alitretinoin—Arthralgia—Docetaxel—head and neck cancer	6.1e-05	0.000864	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	6.06e-05	0.000858	CcSEcCtD
Alitretinoin—ABCB1—head—head and neck cancer	6e-05	0.00337	CbGeAlD
Alitretinoin—RXRA—Generic Transcription Pathway—RARB—head and neck cancer	5.99e-05	0.00107	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Fluorouracil—head and neck cancer	5.97e-05	0.000845	CcSEcCtD
Alitretinoin—Dry mouth—Docetaxel—head and neck cancer	5.97e-05	0.000845	CcSEcCtD
Alitretinoin—RXRA—Metabolism—UROD—head and neck cancer	5.9e-05	0.00106	CbGpPWpGaD
Alitretinoin—Confusional state—Docetaxel—head and neck cancer	5.9e-05	0.000835	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—RARB—head and neck cancer	5.88e-05	0.00105	CbGpPWpGaD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—head and neck cancer	5.86e-05	0.00105	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—YAP1—head and neck cancer	5.85e-05	0.00105	CbGpPWpGaD
Alitretinoin—Oedema—Docetaxel—head and neck cancer	5.85e-05	0.000828	CcSEcCtD
Alitretinoin—Anaphylactic shock—Docetaxel—head and neck cancer	5.85e-05	0.000828	CcSEcCtD
Alitretinoin—Infection—Docetaxel—head and neck cancer	5.81e-05	0.000823	CcSEcCtD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	5.81e-05	0.00104	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	5.79e-05	0.00103	CbGpPWpGaD
Alitretinoin—Shock—Docetaxel—head and neck cancer	5.75e-05	0.000815	CcSEcCtD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	5.75e-05	0.00103	CbGpPWpGaD
Alitretinoin—Nervous system disorder—Docetaxel—head and neck cancer	5.74e-05	0.000812	CcSEcCtD
Alitretinoin—Pruritus—Fluorouracil—head and neck cancer	5.73e-05	0.000812	CcSEcCtD
Alitretinoin—Thrombocytopenia—Docetaxel—head and neck cancer	5.73e-05	0.000811	CcSEcCtD
Alitretinoin—Tachycardia—Docetaxel—head and neck cancer	5.71e-05	0.000808	CcSEcCtD
Alitretinoin—Skin disorder—Docetaxel—head and neck cancer	5.68e-05	0.000804	CcSEcCtD
Alitretinoin—Anorexia—Docetaxel—head and neck cancer	5.58e-05	0.000789	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	5.55e-05	0.000992	CbGpPWpGaD
Alitretinoin—Diarrhoea—Fluorouracil—head and neck cancer	5.54e-05	0.000785	CcSEcCtD
Alitretinoin—RXRB—Gene Expression—RARB—head and neck cancer	5.53e-05	0.00099	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—RARB—head and neck cancer	5.53e-05	0.00099	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—NOTCH1—head and neck cancer	5.48e-05	0.00098	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	5.47e-05	0.000979	CbGpPWpGaD
Alitretinoin—Hypotension—Docetaxel—head and neck cancer	5.47e-05	0.000774	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—YAP1—head and neck cancer	5.45e-05	0.000975	CbGpPWpGaD
Alitretinoin—Dizziness—Fluorouracil—head and neck cancer	5.36e-05	0.000759	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—YAP1—head and neck cancer	5.35e-05	0.000958	CbGpPWpGaD
Alitretinoin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	5.33e-05	0.000754	CcSEcCtD
Alitretinoin—Insomnia—Docetaxel—head and neck cancer	5.29e-05	0.000749	CcSEcCtD
Alitretinoin—Paraesthesia—Docetaxel—head and neck cancer	5.25e-05	0.000743	CcSEcCtD
Alitretinoin—RARB—Gene Expression—YAP1—head and neck cancer	5.25e-05	0.000939	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	5.25e-05	0.000939	CbGpPWpGaD
Alitretinoin—Dyspnoea—Docetaxel—head and neck cancer	5.21e-05	0.000738	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	5.21e-05	0.000932	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	5.21e-05	0.000931	CbGpPWpGaD
Alitretinoin—Somnolence—Docetaxel—head and neck cancer	5.2e-05	0.000736	CcSEcCtD
Alitretinoin—Vomiting—Fluorouracil—head and neck cancer	5.15e-05	0.000729	CcSEcCtD
Alitretinoin—Dyspepsia—Docetaxel—head and neck cancer	5.15e-05	0.000729	CcSEcCtD
Alitretinoin—Rash—Fluorouracil—head and neck cancer	5.11e-05	0.000723	CcSEcCtD
Alitretinoin—Dermatitis—Fluorouracil—head and neck cancer	5.11e-05	0.000723	CcSEcCtD
Alitretinoin—Decreased appetite—Docetaxel—head and neck cancer	5.08e-05	0.00072	CcSEcCtD
Alitretinoin—Headache—Fluorouracil—head and neck cancer	5.08e-05	0.000719	CcSEcCtD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.06e-05	0.000906	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.06e-05	0.000906	CbGpPWpGaD
Alitretinoin—Gastrointestinal disorder—Docetaxel—head and neck cancer	5.05e-05	0.000715	CcSEcCtD
Alitretinoin—Fatigue—Docetaxel—head and neck cancer	5.04e-05	0.000714	CcSEcCtD
Alitretinoin—RXRB—Gene Expression—YAP1—head and neck cancer	5.03e-05	0.0009	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—YAP1—head and neck cancer	5.03e-05	0.0009	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—NOTCH1—head and neck cancer	5.01e-05	0.000896	CbGpPWpGaD
Alitretinoin—Pain—Docetaxel—head and neck cancer	5e-05	0.000708	CcSEcCtD
Alitretinoin—Constipation—Docetaxel—head and neck cancer	5e-05	0.000708	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	4.99e-05	0.000893	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	4.99e-05	0.000893	CbGpPWpGaD
Alitretinoin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	4.97e-05	0.000889	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—NOTCH1—head and neck cancer	4.91e-05	0.000879	CbGpPWpGaD
Alitretinoin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	4.91e-05	0.000878	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Docetaxel—head and neck cancer	4.82e-05	0.000682	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	4.82e-05	0.000862	CbGpPWpGaD
Alitretinoin—Nausea—Fluorouracil—head and neck cancer	4.81e-05	0.000681	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Docetaxel—head and neck cancer	4.78e-05	0.000677	CcSEcCtD
Alitretinoin—RXRB—Generic Transcription Pathway—NOTCH1—head and neck cancer	4.71e-05	0.000843	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—NOTCH1—head and neck cancer	4.71e-05	0.000843	CbGpPWpGaD
Alitretinoin—Body temperature increased—Docetaxel—head and neck cancer	4.62e-05	0.000654	CcSEcCtD
Alitretinoin—Abdominal pain—Docetaxel—head and neck cancer	4.62e-05	0.000654	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.58e-05	0.000819	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—NAT2—head and neck cancer	4.57e-05	0.000818	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	4.52e-05	0.000808	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	4.51e-05	0.000807	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	4.5e-05	0.000805	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.41e-05	0.00079	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.41e-05	0.00079	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	4.38e-05	0.000784	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	4.37e-05	0.000782	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	4.33e-05	0.000775	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Docetaxel—head and neck cancer	4.31e-05	0.00061	CcSEcCtD
Alitretinoin—ABCB1—lymph node—head and neck cancer	4.2e-05	0.00236	CbGeAlD
Alitretinoin—Asthenia—Docetaxel—head and neck cancer	4.2e-05	0.000594	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	4.19e-05	0.00075	CbGpPWpGaD
Alitretinoin—Pruritus—Docetaxel—head and neck cancer	4.14e-05	0.000586	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—TYMS—head and neck cancer	4.05e-05	0.000724	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—TYMS—head and neck cancer	4.05e-05	0.000724	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	4.03e-05	0.000721	CbGpPWpGaD
Alitretinoin—Diarrhoea—Docetaxel—head and neck cancer	4e-05	0.000566	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—GSTM1—head and neck cancer	4e-05	0.000715	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GSTM1—head and neck cancer	4e-05	0.000715	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—STAT3—head and neck cancer	3.89e-05	0.000697	CbGpPWpGaD
Alitretinoin—Dizziness—Docetaxel—head and neck cancer	3.87e-05	0.000547	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	3.86e-05	0.000691	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	3.86e-05	0.000691	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GPX1—head and neck cancer	3.83e-05	0.000685	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GPX1—head and neck cancer	3.83e-05	0.000685	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CYP1A1—head and neck cancer	3.79e-05	0.000678	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CYP1A1—head and neck cancer	3.79e-05	0.000678	CbGpPWpGaD
Alitretinoin—Vomiting—Docetaxel—head and neck cancer	3.72e-05	0.000526	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.69e-05	0.00066	CbGpPWpGaD
Alitretinoin—Rash—Docetaxel—head and neck cancer	3.69e-05	0.000522	CcSEcCtD
Alitretinoin—Dermatitis—Docetaxel—head and neck cancer	3.68e-05	0.000522	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	3.67e-05	0.000656	CbGpPWpGaD
Alitretinoin—Headache—Docetaxel—head and neck cancer	3.66e-05	0.000519	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	3.66e-05	0.000654	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CASP8—head and neck cancer	3.65e-05	0.000652	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.54e-05	0.000633	CbGpPWpGaD
Alitretinoin—Nausea—Docetaxel—head and neck cancer	3.47e-05	0.000492	CcSEcCtD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	3.42e-05	0.000612	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	3.39e-05	0.000606	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	3.32e-05	0.000593	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	3.2e-05	0.000572	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.11e-05	0.000557	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.11e-05	0.000557	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	2.89e-05	0.000517	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—RARB—head and neck cancer	2.88e-05	0.000516	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	2.88e-05	0.000515	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL2—head and neck cancer	2.75e-05	0.000493	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	2.73e-05	0.000489	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	2.7e-05	0.000484	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	2.65e-05	0.000473	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—NOTCH1—head and neck cancer	2.64e-05	0.000472	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	2.63e-05	0.000471	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—YAP1—head and neck cancer	2.62e-05	0.000469	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.6e-05	0.000466	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	2.6e-05	0.000465	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	2.6e-05	0.000465	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	2.59e-05	0.000464	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	2.59e-05	0.000464	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	2.59e-05	0.000464	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.58e-05	0.000461	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—NOTCH1—head and neck cancer	2.46e-05	0.000439	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NAT2—head and neck cancer	2.45e-05	0.000438	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—NOTCH1—head and neck cancer	2.41e-05	0.000432	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—NOTCH1—head and neck cancer	2.37e-05	0.000423	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—UROD—head and neck cancer	2.36e-05	0.000422	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	2.34e-05	0.000419	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—NOTCH1—head and neck cancer	2.31e-05	0.000413	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—NOTCH1—head and neck cancer	2.27e-05	0.000406	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—NOTCH1—head and neck cancer	2.27e-05	0.000406	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	2.26e-05	0.000404	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	2.26e-05	0.000404	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTGS2—head and neck cancer	2.25e-05	0.000403	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTGS2—head and neck cancer	2.25e-05	0.000403	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	2.23e-05	0.000398	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.18e-05	0.000391	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—DPYD—head and neck cancer	2.15e-05	0.000384	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	2.14e-05	0.000383	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	2.11e-05	0.000378	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	2.08e-05	0.000372	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—YAP1—head and neck cancer	2.04e-05	0.000365	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTEN—head and neck cancer	1.97e-05	0.000352	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTEN—head and neck cancer	1.97e-05	0.000352	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—UROD—head and neck cancer	1.88e-05	0.000337	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.84e-05	0.00033	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	1.8e-05	0.000322	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	1.72e-05	0.000309	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	1.54e-05	0.000276	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.53e-05	0.000274	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	1.47e-05	0.000262	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.46e-05	0.000261	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—MAPK3—head and neck cancer	1.46e-05	0.000261	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PIK3CA—head and neck cancer	1.39e-05	0.000248	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PIK3CA—head and neck cancer	1.39e-05	0.000248	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—VEGFA—head and neck cancer	1.35e-05	0.000242	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—STAT3—head and neck cancer	1.34e-05	0.000239	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.34e-05	0.000239	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MAPK3—head and neck cancer	1.33e-05	0.000239	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	1.33e-05	0.000237	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MAPK3—head and neck cancer	1.31e-05	0.000234	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	1.28e-05	0.000229	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MAPK3—head and neck cancer	1.28e-05	0.000229	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MAPK3—head and neck cancer	1.25e-05	0.000224	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MAPK3—head and neck cancer	1.25e-05	0.000224	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—TYMS—head and neck cancer	1.22e-05	0.000219	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MAPK1—head and neck cancer	1.22e-05	0.000218	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—EGFR—head and neck cancer	1.22e-05	0.000218	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTM1—head and neck cancer	1.21e-05	0.000217	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NOTCH1—head and neck cancer	1.18e-05	0.000211	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GPX1—head and neck cancer	1.16e-05	0.000207	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.16e-05	0.000207	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP1A1—head and neck cancer	1.15e-05	0.000205	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—AKT1—head and neck cancer	1.13e-05	0.000203	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—AKT1—head and neck cancer	1.13e-05	0.000203	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.09e-05	0.000195	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.04e-05	0.000186	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.04e-05	0.000186	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—AKT1—head and neck cancer	9.84e-06	0.000176	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NAT2—head and neck cancer	9.8e-06	0.000175	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—HRAS—head and neck cancer	9.77e-06	0.000175	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.43e-06	0.000169	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	9.02e-06	0.000161	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—AKT1—head and neck cancer	9e-06	0.000161	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—AKT1—head and neck cancer	8.83e-06	0.000158	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	8.73e-06	0.000156	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—AKT1—head and neck cancer	8.62e-06	0.000154	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—DPYD—head and neck cancer	8.59e-06	0.000154	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—AKT1—head and neck cancer	8.46e-06	0.000151	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—AKT1—head and neck cancer	8.46e-06	0.000151	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.3e-06	0.000149	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.22e-06	0.000147	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—YAP1—head and neck cancer	8.15e-06	0.000146	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NAT2—head and neck cancer	7.82e-06	0.00014	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	7.37e-06	0.000132	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—DPYD—head and neck cancer	6.86e-06	0.000123	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS2—head and neck cancer	6.82e-06	0.000122	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MAPK3—head and neck cancer	6.54e-06	0.000117	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—YAP1—head and neck cancer	6.51e-06	0.000116	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTEN—head and neck cancer	5.95e-06	0.000106	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—TYMS—head and neck cancer	4.89e-06	8.75e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.89e-06	8.75e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTM1—head and neck cancer	4.84e-06	8.65e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GPX1—head and neck cancer	4.63e-06	8.29e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP1A1—head and neck cancer	4.59e-06	8.2e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—AKT1—head and neck cancer	4.41e-06	7.89e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.26e-06	7.63e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CA—head and neck cancer	4.2e-06	7.51e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—TYMS—head and neck cancer	3.91e-06	6.99e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTM1—head and neck cancer	3.86e-06	6.91e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GPX1—head and neck cancer	3.7e-06	6.62e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP1A1—head and neck cancer	3.66e-06	6.55e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AKT1—head and neck cancer	3.43e-06	6.14e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.01e-06	5.38e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS2—head and neck cancer	2.73e-06	4.88e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTEN—head and neck cancer	2.38e-06	4.25e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS2—head and neck cancer	2.18e-06	3.89e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTEN—head and neck cancer	1.9e-06	3.4e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.68e-06	3e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AKT1—head and neck cancer	1.37e-06	2.45e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.34e-06	2.4e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AKT1—head and neck cancer	1.09e-06	1.96e-05	CbGpPWpGaD
